Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
about
Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into playAn anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced DiseasesCotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and DiseaseSynergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway.Human Genetic Determinants of Viral Diseases.A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.Modulation of the host immune response by respiratory syncytial virus proteins.Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease.Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities.Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System
P2860
Q27468870-4E20B8E5-0800-4BB4-9BF8-2C1FCB49311BQ35893983-C4F5F48B-B9B7-41F8-96A5-285F612D3448Q36246429-E3EAA7D4-D519-47DD-9900-2E180A56BF5CQ36256989-2695201B-1DB2-4F42-9A23-9E9168441577Q36409517-35C6883D-5FCB-4D63-AD67-238FAEFFD82AQ36764982-3CC56A4B-4A80-4532-9002-392A822AAF81Q38635643-305169E2-A9F5-4628-8D44-E5D0F8027193Q38983251-704F1EB7-5261-4B17-8F2C-FE98EA0D05E2Q39154023-358EAE33-5939-42E4-9327-02D42C6BFCEAQ40301155-56FE9F00-4E27-4C75-9030-D2C140AE01C8Q40823850-735DE794-3F2E-4D02-9A1E-4AC4F5F98582Q41813514-2B83E30F-7379-4432-820B-850E3ED81D78Q58566613-77975CCC-4221-44BA-BDC5-61FD21D4A4D2
P2860
Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prophylaxis with a respiratory ...... rom Th2 to Th1 in BALB/c mice.
@ast
Prophylaxis with a respiratory ...... rom Th2 to Th1 in BALB/c mice.
@en
Prophylaxis with a respiratory syncytial virus
@nl
type
label
Prophylaxis with a respiratory ...... rom Th2 to Th1 in BALB/c mice.
@ast
Prophylaxis with a respiratory ...... rom Th2 to Th1 in BALB/c mice.
@en
Prophylaxis with a respiratory syncytial virus
@nl
prefLabel
Prophylaxis with a respiratory ...... rom Th2 to Th1 in BALB/c mice.
@ast
Prophylaxis with a respiratory ...... rom Th2 to Th1 in BALB/c mice.
@en
Prophylaxis with a respiratory syncytial virus
@nl
P2093
P2860
P356
P1433
P1476
Prophylaxis with a respiratory ...... rom Th2 to Th1 in BALB/c mice.
@en
P2093
Kelsey A Gaston
Larry J Anderson
Lia M Haynes
Martin L Moore
Patricia Jorquera
Ralph A Tripp
Sean O Todd
Seyhan Boyoglu-Barnum
Tatiana Chirkova
Thomas R Barnum
P2860
P304
10569-10583
P356
10.1128/JVI.01503-14
P407
P577
2014-07-02T00:00:00Z